Shokat, Kevan M.
Howard Hughes Medical Institute · University of California, San Francisco
37 papers on CoChatORCID 0000-0001-8590-7741
Most cited papers
- Verified
Expanding the scope of electrophiles capable of targeting K-Ras oncogenes
McGregor, L. M., Jenkins, M. L., Kerwin, C., Burke, J. E., & Shokat, K. M. (2017) · Biochemistry
Protein Kinase Regulation and GTPase SignalingClick Chemistry and Applications
Cited by 97
- Verified
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
Thorne, L. G., Bouhaddou, M., Reuschl, A.-K., Zuliani-Alvarez, L., Polacco, B., Pelin, A., Batra, J., Whelan, M. V. X., Ummadi, M., Rojc, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory)
SARS-CoV-2 and COVID-19 Researchinterferon and immune responses
Cited by 91
- Verified
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer
Donnella, H. J., Webber, J. T., Levin, R. S., Camarda, R., Momcilovic, O., Bayani, N., Shah, K. N., Korkola, J. E., Shokat, K. M., Goga, A., et al. (2018) · Nature Chemical Biology
PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies
Cited by 90
- Verified
MST3 Kinase Phosphorylates TAO1/2 to Enable Myosin Va Function in Promoting Spine Synapse Development
Ultanir, S. K., Yadav, S., Hertz, N. T., Oses-Prieto, J. A., Claxton, S., Burlingame, A. L., Shokat, K. M., Jan, L. Y., & Jan, Y.-N. (2014) · Neuron
Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders
Cited by 75
- Verified
PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma
Tan, X., Banerjee, P., Pham, E. A., Rutaganira, F. U. N., Basu, K., Bota-Rabassedas, N., Guo, H.-F., Grzeskowiak, C. L., Liu, X., Yu, J., et al. (2020) · Science Translational Medicine
Cellular transport and secretionCancer, Lipids, and Metabolism
Cited by 70
- Verified
Bifunctional Small‐Molecule Ligands of K‐Ras Induce Its Association with Immunophilin Proteins
Zhang, Z., & Shokat, K. M. (2019) · Angewandte Chemie International Edition
Protein Kinase Regulation and GTPase SignalingSignaling Pathways in Disease
Cited by 66
- Verified
A kinase sequence database: sequence alignments and family assignment
Buzko, O., & Shokat, K. M. (2002) · Bioinformatics
Genomics and Phylogenetic StudiesBioinformatics and Genomic Networks
Cited by 58
- Verified
IFITM proteins assist cellular uptake of diverse linked chemotypes
Lou, K., Wassarman, D. R., Yang, T., Paung, Y., Zhang, Z., O’Loughlin, T. A., Moore, M. K., Egan, R. K., Greninger, P., Benes, C. H., et al. (2022) · Science
Drug Transport and Resistance MechanismsRNA Interference and Gene Delivery
Cited by 42
- Verified
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors
Ruiz-Saenz, A., Atreya, C. E., Wang, C., Pan, B., Dreyer, C. A., Brunen, D., Prahallad, A., Muñoz, D. P., Ramms, D. J., Burghi, V., et al. (2023) · Nature Cancer
Colorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways
Cited by 39
- Verified
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib
Leyte-Vidal, A., DeFilippis, R., Outhwaite, I. R., Kwan, I., Lee, J. Y., Leavitt, C., Miller, K. B., Rea, D., Rangwala, A. M., Lou, K., et al. (2024) · Leukemia
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 17
- Verified · note
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Li, H., Melnyk, J. E., Fu, B. X. H., Shrestha, R., Zhang, M., Sjöström, M., Feng, S., Anderson, J. A., Han, W., Chesner, L. N., et al. (2025) · Nature Genetics
Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer
Cited by 10
- Verified
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity
Wassarman, D. R., Pfaff, P., Paulo, J. A., Gygi, S. P., Shokat, K. M., & Kranzusch, P. J. (2025) · Science
interferon and immune responsesBacteriophages and microbial interactions
Cited by 9
- Verified
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity
Wassarman, D. R., Pfaff, P., Paulo, J. A., Gygi, S. P., Shokat, K. M., & Kranzusch, P. J. (2025) · Science
interferon and immune responsesBacteriophages and microbial interactions
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free